Seven subsets, two fates: mouse γδ T cells in cancer immunity

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• The role of gamma delta (γδ) T cells in cancer defense has been recognized for over 20 years.
• Research, particularly using mouse models, has revealed diverse functions of tumor-associated γδ T cells across different cancer types.

Purpose of the Study:

• To review the distinct roles of specific γδ T cell subsets (Vγ1+, Vγ4+, Vγ5+, Vγ6+, Vγ7+) in cancer progression.
• To explore both the protective and pathogenic functions of these cells in response to tumors.
• To examine the potential for exploiting the mechanisms of these cells for cancer therapy in humans.

Main Methods:

• Review of existing scientific literature and data from mouse models of cancer.
• Analysis of studies focusing on individual γδ T cell subsets and their interactions with tumors.
• Examination of the mechanisms underlying γδ T cell functions in tumor development and metastasis.

Main Results:

• Different γδ T cell subsets (Vγ1+, Vγ4+, Vγ5+, Vγ6+, Vγ7+) exhibit varied contributions to cancer progression.
• These subsets can exert both anti-tumor (protective) and pro-tumor (pathogenic) effects.
• The specific functions are often dependent on the cancer type and the tumor microenvironment.

Conclusions:

• Understanding the specific roles of distinct γδ T cell subsets is key to harnessing their therapeutic potential.
• Targeting these subsets or their mechanisms may offer novel strategies for cancer treatment.
• Further research is needed to translate findings from mouse models to human cancer therapies.